645 related articles for article (PubMed ID: 15742435)
1. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.
Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR
J Rheumatol; 2005 Mar; 32(3):443-53. PubMed ID: 15742435
[TBL] [Abstract][Full Text] [Related]
2. Costs of rheumatoid arthritis: new estimates from the human capital method and comparison to the willingness-to-pay method.
Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR
Med Decis Making; 2007; 27(2):138-50. PubMed ID: 17409364
[TBL] [Abstract][Full Text] [Related]
3. Willingness to pay for drug abuse treatment: results from a contingent valuation study in Taiwan.
Tang CH; Liu JT; Chang CW; Chang WY
Health Policy; 2007 Jul; 82(2):251-62. PubMed ID: 17084480
[TBL] [Abstract][Full Text] [Related]
4. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
[TBL] [Abstract][Full Text] [Related]
5. Do utility values and willingness to pay suitably reflect health outcome in hip and knee osteoarthritis? A comparative analysis with the WOMAC Index.
Ethgen O; Tancredi A; Lejeune E; Kvasz A; Zegels B; Reginster JY
J Rheumatol; 2003 Nov; 30(11):2452-9. PubMed ID: 14677192
[TBL] [Abstract][Full Text] [Related]
6. Identifying factors that affect patients' willingness to pay for inhaled insulin.
Pinto SL; Holiday-Goodman M; Black CD; Lesch D
Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826
[TBL] [Abstract][Full Text] [Related]
7. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.
Michaud K; Messer J; Choi HK; Wolfe F
Arthritis Rheum; 2003 Oct; 48(10):2750-62. PubMed ID: 14558079
[TBL] [Abstract][Full Text] [Related]
8. Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation study.
Greenberg D; Bakhai A; Neumann PJ; Cohen DJ
Health Policy; 2004 Nov; 70(2):207-16. PubMed ID: 15364150
[TBL] [Abstract][Full Text] [Related]
9. Stated and actual altruistic willingness to pay for insecticide-treated nets in Nigeria: validity of open-ended and binary with follow-up questions.
Onwujekwe O; Uzochukwu B
Health Econ; 2004 May; 13(5):477-92. PubMed ID: 15127427
[TBL] [Abstract][Full Text] [Related]
10. Willingness-to-pay for community-based insurance in Burkina Faso.
Dong H; Kouyate B; Cairns J; Mugisha F; Sauerborn R
Health Econ; 2003 Oct; 12(10):849-62. PubMed ID: 14508869
[TBL] [Abstract][Full Text] [Related]
11. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
Hu SW; Holt EW; Husni ME; Qureshi AA
Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
[TBL] [Abstract][Full Text] [Related]
12. Willingness to pay for community-based health insurance in Nigeria: do economic status and place of residence matter?
Onwujekwe O; Okereke E; Onoka C; Uzochukwu B; Kirigia J; Petu A
Health Policy Plan; 2010 Mar; 25(2):155-61. PubMed ID: 20156920
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and construct validity of the parent willingness-to-pay technique for children with juvenile idiopathic arthritis.
Barron AC; Lee TL; Taylor J; Moore T; Passo MH; Graham TB; Griffin TA; Grom AA; Lovell DJ; Brunner HI
Arthritis Rheum; 2004 Dec; 51(6):899-908. PubMed ID: 15593249
[TBL] [Abstract][Full Text] [Related]
14. [Acceptance and understandability of various methods of health valuations for the chronically ill: willingness to pay, visual analogue scale and rating scale].
Meder M; Farin E
Gesundheitswesen; 2009 Nov; 71(11):e62-71. PubMed ID: 20094981
[TBL] [Abstract][Full Text] [Related]
15. Patient preferences for depression treatment programs and willingness to pay for treatment.
Morey E; Thacher JA; Craighead WE
J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
[TBL] [Abstract][Full Text] [Related]
16. Perception of the economic value of primary care services: a Willingness to Pay study.
Martín-Fernández J; Gómez-Gascón T; Oliva-Moreno J; del Cura-González MI; Domínguez-Bidagor J; Beamud-Lagos M; Sanz-Cuesta T
Health Policy; 2010 Mar; 94(3):266-72. PubMed ID: 19945763
[TBL] [Abstract][Full Text] [Related]
17. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.
Merkesdal S; Ruof J; Huelsemann JL; Mittendorf T; Handelmann S; Mau W; Zeidler H
Arthritis Rheum; 2005 Apr; 53(2):234-40. PubMed ID: 15818718
[TBL] [Abstract][Full Text] [Related]
18. A cost-benefit analysis using contingent valuation techniques: a feasibility study in spinal surgery.
Haefeli M; Elfering A; McIntosh E; Gray A; Sukthankar A; Boos N
Value Health; 2008; 11(4):575-88. PubMed ID: 18179657
[TBL] [Abstract][Full Text] [Related]
19. An assessment of the burden of migraine using the willingness to pay model.
Hamelsky SW; Lipton RB; Stewart WF
Cephalalgia; 2005 Feb; 25(2):87-100. PubMed ID: 15658945
[TBL] [Abstract][Full Text] [Related]
20. Using willingness to pay to measure family members' preferences in mental health.
Mulvaney-Day NE
J Ment Health Policy Econ; 2005 Jun; 8(2):71-81. PubMed ID: 15998979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
